US Stock MarketDetailed Quotes

TPTX Turning Point Therapeutics

Watchlist
  • 0.000
  • 0.0000.00%
Close May 1 09:30 ET
0Market Cap0.00P/E (TTM)

Turning Point Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-148.22%-105.3M
-272.77%-58.33M
-85.87%-153.89M
-61.91%-54.15M
-2,395.59%-41.67M
-82.10%-42.42M
43.85%-15.65M
-43.53%-82.79M
-138.92%-33.45M
110.97%1.82M
Net income from continuing operations
-118.73%-123.09M
-109.68%-74.45M
-50.39%-236.55M
-65.59%-78.45M
-274.61%-66.33M
-78.68%-56.27M
41.53%-35.5M
-118.06%-157.29M
-126.04%-47.38M
13.56%-17.71M
Depreciation and amortization
54.82%1.32M
98.10%1.25M
65.78%3.97M
109.88%1.27M
100.33%1.21M
43.10%850K
7.65%633K
51.55%2.39M
10.36%607K
29.06%604K
Change In working capital
17.85%-1.37M
-305.87%-1.12M
121.63%14.81M
215.50%7.59M
-16.17%8.33M
-962.18%-1.66M
109.30%545K
339.89%6.68M
-10.62%2.41M
2,047.08%9.94M
-Change in prepaid assets
37.55%-4.14M
57.92%1.64M
-20.26%-2.86M
116.81%247K
42.52%2.49M
-4,020.12%-6.63M
136.75%1.04M
54.60%-2.37M
-140.43%-1.47M
318.95%1.75M
-Change in payables and accrued expense
-188.51%-2.74M
-19.61%3.4M
90.84%13.75M
253.24%3.87M
-59.43%2.55M
383.79%3.1M
361.00%4.23M
405.54%7.2M
211.97%1.1M
837.44%6.28M
-Change in other current assets
--2K
---20K
----
----
----
--0
--0
----
----
----
-Change in other working capital
195.97%5.51M
-30.00%-6.14M
111.45%3.92M
25.10%3.48M
72.40%3.3M
66.85%1.86M
-19.33%-4.72M
-65.21%1.85M
-5.82%2.78M
-9.42%1.91M
Cash from discontinued investing activities
Operating cash flow
-148.22%-105.3M
-272.77%-58.33M
-85.87%-153.89M
-61.91%-54.15M
-2,395.59%-41.67M
-82.10%-42.42M
43.85%-15.65M
-43.53%-82.79M
-138.92%-33.45M
110.97%1.82M
Investing cash flow
Cash flow from continuing investing activities
1,030.11%76.94M
23.46%-60.41M
102.60%5.46M
144.00%75.22M
110.88%17.44M
-107.40%-8.27M
-931.64%-78.93M
41.83%-210.03M
-55.28%-170.98M
-100.22%-160.37M
Net PPE purchase and sale
-108.89%-1.53M
-212.59%-447K
-92.01%-2.43M
0.77%-387K
-624.22%-1.17M
-182.24%-731K
68.50%-143K
27.52%-1.26M
48.75%-390K
79.75%-161K
Net investment purchase and sale
1,140.53%78.47M
23.89%-59.97M
103.78%7.89M
144.32%75.61M
111.62%18.61M
-106.73%-7.54M
-892.24%-78.79M
41.90%-208.77M
-56.00%-170.59M
-102.03%-160.21M
Cash from discontinued investing activities
Investing cash flow
1,030.11%76.94M
23.46%-60.41M
102.60%5.46M
144.00%75.22M
110.88%17.44M
-107.40%-8.27M
-931.64%-78.93M
41.83%-210.03M
-55.28%-170.98M
-100.22%-160.37M
Financing cash flow
Cash flow from continuing financing activities
-3.93%8.97M
-95.91%396K
-96.99%24M
-99.42%2.61M
503.81%2.38M
-97.35%9.34M
38,616.00%9.68M
118.24%798.74M
874,949.02%446.17M
-99.79%394K
Net common stock issuance
----
----
--0
--0
----
----
----
115.40%785.47M
63,808.96%433.86M
--0
Proceeds from stock option exercised by employees
-3.93%8.97M
-95.91%396K
80.90%24M
-78.65%2.61M
368.31%2.38M
1,645.98%9.34M
38,616.00%9.68M
890.96%13.27M
1,836.67%12.2M
429.17%508K
Cash from discontinued financing activities
Financing cash flow
-3.93%8.97M
-95.91%396K
-96.99%24M
-99.42%2.61M
503.81%2.38M
-97.35%9.34M
38,616.00%9.68M
118.24%798.74M
874,949.02%446.17M
-99.79%394K
Net cash flow
Beginning cash position
-33.64%311.41M
-22.45%429.76M
1,048.29%554.17M
30.01%406.08M
-9.07%427.92M
1,472.74%469.27M
1,050.02%554.17M
-52.23%48.26M
81.16%312.35M
497.34%470.59M
Current changes in cash
53.12%-19.39M
-39.40%-118.35M
-124.59%-124.42M
-90.21%23.68M
86.19%-21.84M
-109.38%-41.35M
-362.67%-84.9M
1,058.75%505.91M
294.71%241.75M
-268.91%-158.16M
End cash Position
-31.76%292.02M
-33.64%311.41M
-22.45%429.76M
-22.45%429.76M
30.01%406.08M
-9.07%427.92M
1,472.74%469.27M
1,048.29%554.17M
1,048.29%554.17M
81.16%312.35M
Free cash flow
-147.56%-106.83M
-272.22%-58.78M
-85.96%-156.31M
-61.18%-54.54M
-2,689.54%-42.83M
-83.20%-43.15M
44.24%-15.79M
-41.44%-84.06M
-129.24%-33.84M
109.54%1.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -148.22%-105.3M-272.77%-58.33M-85.87%-153.89M-61.91%-54.15M-2,395.59%-41.67M-82.10%-42.42M43.85%-15.65M-43.53%-82.79M-138.92%-33.45M110.97%1.82M
Net income from continuing operations -118.73%-123.09M-109.68%-74.45M-50.39%-236.55M-65.59%-78.45M-274.61%-66.33M-78.68%-56.27M41.53%-35.5M-118.06%-157.29M-126.04%-47.38M13.56%-17.71M
Depreciation and amortization 54.82%1.32M98.10%1.25M65.78%3.97M109.88%1.27M100.33%1.21M43.10%850K7.65%633K51.55%2.39M10.36%607K29.06%604K
Change In working capital 17.85%-1.37M-305.87%-1.12M121.63%14.81M215.50%7.59M-16.17%8.33M-962.18%-1.66M109.30%545K339.89%6.68M-10.62%2.41M2,047.08%9.94M
-Change in prepaid assets 37.55%-4.14M57.92%1.64M-20.26%-2.86M116.81%247K42.52%2.49M-4,020.12%-6.63M136.75%1.04M54.60%-2.37M-140.43%-1.47M318.95%1.75M
-Change in payables and accrued expense -188.51%-2.74M-19.61%3.4M90.84%13.75M253.24%3.87M-59.43%2.55M383.79%3.1M361.00%4.23M405.54%7.2M211.97%1.1M837.44%6.28M
-Change in other current assets --2K---20K--------------0--0------------
-Change in other working capital 195.97%5.51M-30.00%-6.14M111.45%3.92M25.10%3.48M72.40%3.3M66.85%1.86M-19.33%-4.72M-65.21%1.85M-5.82%2.78M-9.42%1.91M
Cash from discontinued investing activities
Operating cash flow -148.22%-105.3M-272.77%-58.33M-85.87%-153.89M-61.91%-54.15M-2,395.59%-41.67M-82.10%-42.42M43.85%-15.65M-43.53%-82.79M-138.92%-33.45M110.97%1.82M
Investing cash flow
Cash flow from continuing investing activities 1,030.11%76.94M23.46%-60.41M102.60%5.46M144.00%75.22M110.88%17.44M-107.40%-8.27M-931.64%-78.93M41.83%-210.03M-55.28%-170.98M-100.22%-160.37M
Net PPE purchase and sale -108.89%-1.53M-212.59%-447K-92.01%-2.43M0.77%-387K-624.22%-1.17M-182.24%-731K68.50%-143K27.52%-1.26M48.75%-390K79.75%-161K
Net investment purchase and sale 1,140.53%78.47M23.89%-59.97M103.78%7.89M144.32%75.61M111.62%18.61M-106.73%-7.54M-892.24%-78.79M41.90%-208.77M-56.00%-170.59M-102.03%-160.21M
Cash from discontinued investing activities
Investing cash flow 1,030.11%76.94M23.46%-60.41M102.60%5.46M144.00%75.22M110.88%17.44M-107.40%-8.27M-931.64%-78.93M41.83%-210.03M-55.28%-170.98M-100.22%-160.37M
Financing cash flow
Cash flow from continuing financing activities -3.93%8.97M-95.91%396K-96.99%24M-99.42%2.61M503.81%2.38M-97.35%9.34M38,616.00%9.68M118.24%798.74M874,949.02%446.17M-99.79%394K
Net common stock issuance ----------0--0------------115.40%785.47M63,808.96%433.86M--0
Proceeds from stock option exercised by employees -3.93%8.97M-95.91%396K80.90%24M-78.65%2.61M368.31%2.38M1,645.98%9.34M38,616.00%9.68M890.96%13.27M1,836.67%12.2M429.17%508K
Cash from discontinued financing activities
Financing cash flow -3.93%8.97M-95.91%396K-96.99%24M-99.42%2.61M503.81%2.38M-97.35%9.34M38,616.00%9.68M118.24%798.74M874,949.02%446.17M-99.79%394K
Net cash flow
Beginning cash position -33.64%311.41M-22.45%429.76M1,048.29%554.17M30.01%406.08M-9.07%427.92M1,472.74%469.27M1,050.02%554.17M-52.23%48.26M81.16%312.35M497.34%470.59M
Current changes in cash 53.12%-19.39M-39.40%-118.35M-124.59%-124.42M-90.21%23.68M86.19%-21.84M-109.38%-41.35M-362.67%-84.9M1,058.75%505.91M294.71%241.75M-268.91%-158.16M
End cash Position -31.76%292.02M-33.64%311.41M-22.45%429.76M-22.45%429.76M30.01%406.08M-9.07%427.92M1,472.74%469.27M1,048.29%554.17M1,048.29%554.17M81.16%312.35M
Free cash flow -147.56%-106.83M-272.22%-58.78M-85.96%-156.31M-61.18%-54.54M-2,689.54%-42.83M-83.20%-43.15M44.24%-15.79M-41.44%-84.06M-129.24%-33.84M109.54%1.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg